Toxoplasmosis in allo-SCT patients: Risk factors and outcomes at a transplantation center with a low incidence

Bone Marrow Transplantation

Volumn 46, Issue 2, 2011, Pages 273-277

  Mulanovich, V E ^a   Ahmed, S I ^b   Ozturk T ^c   Khokhar, F A ^d   Kontoyiannis, D P ^a   De Lima, M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b IPC the Hospitalist Company   (United States)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

central nervous system infection; opportunistic infection; SCT; toxoplasmosis

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; FLUDARABINE; FOLINIC ACID; IMMUNOGLOBULIN G; MEPREDNISONE; PROTOZOON ANTIBODY; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOPSY; B CELL LYMPHOMA; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE SEPSIS; HEALTH CENTER; HLA MATCHING; HUMAN; INCIDENCE; INFECTION RISK; INTERNATIONAL CLASSIFICATION OF DISEASES; LUNG ASPERGILLOSIS; LUNG HEMORRHAGE; LYMPHOCYTOPENIA; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE DATABASE; RETROSPECTIVE STUDY; SERODIAGNOSIS; SKIN DISEASE; T CELL LYMPHOMA; TOXOPLASMOSIS; TUBERCULOSIS; UNITED STATES;

COMORBIDITY; DNA, PROTOZOAN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; TOXOPLASMOSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79951683618     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.102     Document Type: Article

References (14)

1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976. (Pubitemid 38759657)
2. de Medeiros BC, de Medeiros CR, Werner B, Loddo G, Pasquini R, Bleggi-Torres LF. Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transpl Infect Dis 2001; 3: 24-28. (Pubitemid 32148447)
3. Fricker-Hidalgo H, Bulabois CE, Brenier-Pinchart MP, Hamidfar R, Garban F, Brion JP et al. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis 2009; 48: e9-e15.
4. Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000; 31: 1188-1195.
5. Matsuo Y, Takeishi S, Miyamoto T, Nonami A, Kikushige Y, Kunisaki Y et al. Toxoplasmosis encephalitis following severe graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group. Eur J Haematol 2007; 79: 317-321. (Pubitemid 47390132)
6. Roemer E, Blau IW, Basara N, Kiehl MG, Bischoff M, Gunzelmann S et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infect Dis 2001; 32: E1-E8.
7. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994; 13: 549-557. (Pubitemid 24141181)
8. Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Bone Marrow Transplant 1997; 19: 685-689. (Pubitemid 27182491)
9. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg 2007; 77: 405-410. (Pubitemid 351844310)
10. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009; 49: 878-884.
11. Martino R, Bretagne S, Einsele H, Maertens J, Ullmann AJ, Parody R et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005; 40: 67-78. (Pubitemid 40053461)
12. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143-1238.
13. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002; 29: 691-698. (Pubitemid 34591313)
14. Foot AB, Garin YJ, Ribaud P, Devergie A, Derouin F, Gluckman E. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Bone Marrow Transplant 1994; 14: 241-245. (Pubitemid 24262547)